$5.56 Billion is the total value of Eventide Asset Management's 155 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 27.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ODFL | Sell | OLD DOMINION FREIGHT LINE IN | $181,618,064 | +10.4% | 443,902 | -0.2% | 3.26% | +17.4% |
TT | Buy | TRANE TECHNOLOGIES PLC | $160,424,704 | +6.3% | 790,620 | +0.2% | 2.88% | +13.0% |
ARGX | Sell | ARGENX SEsponsored adr | $157,987,759 | +23.2% | 321,355 | -2.3% | 2.84% | +31.0% |
ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $156,749,622 | -19.2% | 7,814,039 | +13.6% | 2.82% | -14.1% |
FLYW | Buy | FLYWIRE CORPORATION | $129,832,737 | +2.8% | 4,071,268 | +0.1% | 2.33% | +9.3% |
EXAS | Buy | EXACT SCIENCES CORP | $127,438,371 | -27.3% | 1,868,050 | +0.0% | 2.29% | -22.7% |
MIRM | Buy | MIRUM PHARMACEUTICALS INC | $125,091,097 | +39.8% | 3,958,579 | +14.4% | 2.25% | +48.7% |
PANW | Sell | PALO ALTO NETWORKS INC | $124,939,640 | -31.2% | 532,928 | -25.0% | 2.25% | -26.8% |
MTD | Sell | METTLER TOLEDO INTERNATIONAL | $120,101,491 | -23.6% | 108,388 | -9.6% | 2.16% | -18.8% |
ROP | Buy | ROPER TECHNOLOGIES INC | $114,826,178 | +0.8% | 237,107 | +0.1% | 2.06% | +7.3% |
WCN | Sell | WASTE CONNECTIONS INC | $108,041,933 | -6.6% | 804,482 | -0.6% | 1.94% | -0.7% |
GH | Sell | GUARDANT HEALTH INC | $106,393,669 | -25.9% | 3,589,530 | -10.5% | 1.91% | -21.2% |
DLO | Sell | DLOCAL LTD | $104,896,016 | +50.8% | 5,471,884 | -4.0% | 1.88% | +60.3% |
POOL | Buy | POOL CORP | $102,235,954 | -3.2% | 287,099 | +1.9% | 1.84% | +3.0% |
IDXX | Sell | IDEXX LABS INC | $97,976,465 | -18.9% | 224,064 | -6.9% | 1.76% | -13.8% |
GLBE | Sell | GLOBAL E ONLINE LTD | $97,396,660 | -3.4% | 2,450,847 | -0.5% | 1.75% | +2.8% |
LOW | Sell | LOWES COS INC | $92,790,168 | -8.3% | 446,450 | -0.5% | 1.67% | -2.5% |
CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $83,588,568 | +14.4% | 499,394 | +0.4% | 1.50% | +21.7% |
DHI | Buy | D R HORTON INC | $80,730,819 | -3.6% | 751,194 | +9.1% | 1.45% | +2.5% |
HZNP | Buy | HORIZON THERAPEUTICS PUB L | $79,795,095 | +12.5% | 689,732 | +0.0% | 1.43% | +19.6% |
TTD | Buy | THE TRADE DESK INC | $79,137,972 | +1.8% | 1,012,642 | +0.6% | 1.42% | +8.2% |
APTV | Sell | APTIV PLC | $77,361,700 | -6.3% | 784,681 | -2.9% | 1.39% | -0.4% |
XMTR | Buy | XOMETRY INC | $74,021,135 | +9.5% | 4,359,313 | +36.6% | 1.33% | +16.5% |
LAD | Buy | LITHIA MTRS INC | $73,098,310 | -1.6% | 247,514 | +1.3% | 1.31% | +4.6% |
LRCX | Sell | LAM RESEARCH CORP | $72,655,805 | -3.7% | 115,921 | -1.2% | 1.31% | +2.4% |
EVH | Buy | EVOLENT HEALTH INCcl a | $71,858,336 | -10.1% | 2,638,940 | +0.0% | 1.29% | -4.4% |
SWAV | Buy | SHOCKWAVE MED INC | $70,823,255 | +2.3% | 355,717 | +46.7% | 1.27% | +8.8% |
COUR | Buy | COURSERA INC | $69,039,178 | +55.9% | 3,693,910 | +8.6% | 1.24% | +65.7% |
HUBS | Sell | HUBSPOT INC | $68,995,803 | -27.3% | 140,093 | -21.5% | 1.24% | -22.7% |
DDOG | Buy | DATADOG INC | $66,580,687 | +36.5% | 730,933 | +47.4% | 1.20% | +45.3% |
COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $58,810,315 | +4.0% | 2,631,334 | +0.0% | 1.06% | +10.6% |
KRTX | Sell | KARUNA THERAPEUTICS INC | $57,463,546 | -22.1% | 339,840 | -0.0% | 1.03% | -17.1% |
Buy | TOAST INCcl a | $54,805,366 | +51.4% | 2,926,074 | +82.4% | 0.98% | +60.9% | |
TREX | Buy | TREX CO INC | $54,390,324 | -6.0% | 882,530 | +0.0% | 0.98% | 0.0% |
ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $53,884,014 | +4.9% | 575,438 | +0.0% | 0.97% | +11.5% |
DV | Buy | DOUBLEVERIFY HLDGS INC | $53,678,758 | -26.8% | 1,920,528 | +1.9% | 0.96% | -22.2% |
TMDX | Buy | TRANSMEDICS GROUP INC | $50,663,241 | +794.3% | 925,356 | +1271.7% | 0.91% | +849.0% |
LNG | Buy | CHENIERE ENERGY INC | $49,989,641 | +8.9% | 301,215 | +0.0% | 0.90% | +15.7% |
SPT | Sell | SPROUT SOCIAL INC | $49,327,379 | +6.6% | 988,921 | -1.4% | 0.89% | +13.4% |
TRGP | Buy | TARGA RES CORP | $49,259,341 | +65.2% | 574,654 | +46.7% | 0.88% | +75.6% |
ENTG | Sell | ENTEGRIS INC | $47,671,533 | -15.3% | 507,630 | -0.0% | 0.86% | -9.9% |
MPWR | Buy | MONOLITHIC PWR SYS INC | $45,425,688 | -13.6% | 98,324 | +1.0% | 0.82% | -8.2% |
FIVN | Buy | FIVE9 INC | $44,627,608 | -21.9% | 694,053 | +0.1% | 0.80% | -17.0% |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $44,032,000 | -5.8% | 1,600,000 | +16.1% | 0.79% | +0.1% |
SHLS | Sell | SHOALS TECHNOLOGIES GROUP INcl a | $42,569,512 | -32.2% | 2,332,576 | -5.0% | 0.76% | -27.9% |
NVT | Sell | NVENT ELECTRIC PLC | $41,751,722 | +0.7% | 787,917 | -1.8% | 0.75% | +7.0% |
ASML | Buy | ASML HOLDING N V | $41,142,036 | -18.1% | 69,891 | +0.9% | 0.74% | -13.0% |
LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $36,778,298 | -10.5% | 428,003 | +0.0% | 0.66% | -4.9% |
Buy | MARINUS PHARMACEUTICALS INC | $36,466,476 | +5.8% | 4,529,997 | +42.8% | 0.66% | +12.5% | |
SNPS | Buy | SYNOPSYS INC | $36,260,925 | +6.5% | 79,005 | +1.0% | 0.65% | +13.2% |
CDW | Sell | CDW CORP | $34,038,930 | +9.2% | 168,710 | -0.6% | 0.61% | +16.1% |
NARI | INARI MED INC | $33,544,576 | +12.5% | 512,914 | 0.0% | 0.60% | +19.6% | |
MNDY | New | MONDAY COM LTD | $32,419,899 | – | 203,617 | +100.0% | 0.58% | – |
KLAC | Buy | KLA CORP | $30,746,273 | +4.4% | 67,035 | +10.4% | 0.55% | +11.0% |
CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $30,298,577 | +286.7% | 1,018,782 | +134.3% | 0.54% | +312.9% |
HASI | Sell | HANNON ARMSTRONG SUST INFR C | $29,219,833 | -15.2% | 1,378,294 | -0.0% | 0.52% | -9.9% |
ORLY | Buy | OREILLY AUTOMOTIVE INC | $27,931,086 | -4.0% | 30,732 | +1.0% | 0.50% | +2.2% |
SGEN | Buy | SEAGEN INC | $27,789,529 | +10.2% | 130,990 | +0.0% | 0.50% | +17.1% |
RPRX | Sell | ROYALTY PHARMA PLC | $27,252,522 | -14.7% | 1,004,146 | -3.4% | 0.49% | -9.3% |
Buy | AURA BIOSCIENCES INC | $27,133,398 | -25.2% | 3,024,905 | +3.0% | 0.49% | -20.4% | |
BEP | BROOKFIELD RENEWABLE PARTNERpartnership unit | $26,870,640 | -26.3% | 1,236,000 | 0.0% | 0.48% | -21.6% | |
WMB | Sell | WILLIAMS COS INC | $26,487,651 | -9.6% | 786,217 | -12.5% | 0.48% | -3.8% |
FANG | Buy | DIAMONDBACK ENERGY INC | $26,283,601 | +75.9% | 169,703 | +49.2% | 0.47% | +86.6% |
MRTX | MIRATI THERAPEUTICS INC | $26,136,000 | +20.6% | 600,000 | 0.0% | 0.47% | +28.4% | |
AKRO | Buy | AKERO THERAPEUTICS INC | $25,991,848 | +46.8% | 513,876 | +35.5% | 0.47% | +56.2% |
INSP | Buy | INSPIRE MED SYS INC | $24,822,860 | -29.3% | 125,090 | +15.6% | 0.45% | -24.9% |
AJG | Buy | GALLAGHER ARTHUR J & CO | $24,743,853 | +15.5% | 108,559 | +11.2% | 0.44% | +22.9% |
AXSM | New | AXSOME THERAPEUTICS INC | $24,231,702 | – | 346,712 | +100.0% | 0.44% | – |
FERG | New | FERGUSON PLC NEW | $24,012,949 | – | 146,002 | +100.0% | 0.43% | – |
SHW | Buy | SHERWIN WILLIAMS CO | $23,749,491 | -2.9% | 93,117 | +1.1% | 0.43% | +3.4% |
PRVA | PRIVIA HEALTH GROUP INC | $23,000,000 | -11.9% | 1,000,000 | 0.0% | 0.41% | -6.3% | |
IRTC | IRHYTHM TECHNOLOGIES INC | $22,540,865 | -9.6% | 239,135 | 0.0% | 0.40% | -4.0% | |
ISRG | Buy | INTUITIVE SURGICAL INC | $22,330,664 | -13.0% | 76,399 | +1.8% | 0.40% | -7.6% |
STE | Sell | STERIS PLC | $22,265,645 | -11.4% | 101,475 | -9.1% | 0.40% | -5.9% |
BPMC | BLUEPRINT MEDICINES CORP | $22,021,470 | -20.5% | 438,500 | 0.0% | 0.40% | -15.4% | |
PRTA | PROTHENA CORP PLC | $21,478,729 | -29.3% | 445,155 | 0.0% | 0.39% | -24.9% | |
PNR | Buy | PENTAIR PLC | $21,383,688 | +0.2% | 330,250 | +0.0% | 0.38% | +6.4% |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $21,047,250 | +58.8% | 1,425,000 | +38.9% | 0.38% | +68.8% |
COGT | Sell | COGENT BIOSCIENCES INC | $20,962,500 | -48.5% | 2,150,000 | -37.5% | 0.38% | -45.3% |
IMGN | IMMUNOGEN INC | $20,631,000 | -15.9% | 1,300,000 | 0.0% | 0.37% | -10.6% | |
AMYLYX PHARMACEUTICALS INC | $20,449,285 | -15.1% | 1,116,837 | 0.0% | 0.37% | -9.6% | ||
WDAY | Sell | WORKDAY INCcl a | $20,071,287 | -33.5% | 93,420 | -30.1% | 0.36% | -29.2% |
PCVX | New | VAXCYTE INC | $20,035,140 | – | 393,000 | +100.0% | 0.36% | – |
BILL | New | BILL HOLDINGS INC | $19,891,544 | – | 183,214 | +100.0% | 0.36% | – |
ROIVANT SCIENCES LTD | $19,742,704 | +15.9% | 1,690,300 | 0.0% | 0.36% | +23.3% | ||
RGEN | REPLIGEN CORP | $18,922,190 | +12.4% | 119,000 | 0.0% | 0.34% | +19.3% | |
BBIO | Sell | BRIDGEBIO PHARMA INC | $18,905,365 | +16.8% | 716,927 | -23.8% | 0.34% | +24.1% |
BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $18,581,079 | -24.0% | 776,152 | +0.0% | 0.33% | -19.1% |
KROS | KEROS THERAPEUTICS INC | $18,490,400 | -20.7% | 580,000 | 0.0% | 0.33% | -15.7% | |
RCKT | ROCKET PHARMACEUTICALS INC | $18,400,020 | +3.1% | 898,000 | 0.0% | 0.33% | +9.6% | |
ROL | New | ROLLINS INC | $18,303,944 | – | 490,328 | +100.0% | 0.33% | – |
NOVT | Buy | NOVANTA INC | $18,077,456 | -22.1% | 126,028 | +0.0% | 0.32% | -17.1% |
CMS | Buy | CMS ENERGY CORP | $17,598,423 | -6.8% | 331,358 | +3.1% | 0.32% | -0.9% |
NEP | Sell | NEXTERA ENERGY PARTNERS LP | $17,474,262 | -78.4% | 588,359 | -57.3% | 0.31% | -77.0% |
VCYT | VERACYTE INC | $16,345,560 | -12.3% | 732,000 | 0.0% | 0.29% | -6.7% | |
CYTK | CYTOKINETICS INC | $16,379,760 | -9.7% | 556,000 | 0.0% | 0.29% | -4.2% | |
HLI | New | HOULIHAN LOKEY INCcl a | $16,028,580 | – | 149,632 | +100.0% | 0.29% | – |
INSM | Sell | INSMED INC | $16,038,421 | -16.7% | 635,185 | -30.4% | 0.29% | -11.4% |
RPHM | Buy | RENEO PHARMACEUTICALS INC | $15,825,051 | +37.8% | 2,078,142 | +18.8% | 0.28% | +46.4% |
MSCI | Sell | MSCI INC | $15,198,969 | +6.5% | 29,623 | -2.6% | 0.27% | +13.3% |
NBIX | NEUROCRINE BIOSCIENCES INC | $15,187,500 | +19.3% | 135,000 | 0.0% | 0.27% | +27.0% | |
SRPT | SAREPTA THERAPEUTICS INC | $14,866,784 | +5.9% | 122,643 | 0.0% | 0.27% | +12.7% | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $14,537,176 | +2.1% | 164,299 | 0.0% | 0.26% | +8.3% | |
XENE | XENON PHARMACEUTICALS INC | $14,139,029 | -11.3% | 413,906 | 0.0% | 0.25% | -5.6% | |
BCRX | BIOCRYST PHARMACEUTICALS INC | $13,947,600 | +0.6% | 1,970,000 | 0.0% | 0.25% | +7.3% | |
VRNA | New | VERONA PHARMA PLCsponsored ads | $13,855,000 | – | 850,000 | +100.0% | 0.25% | – |
ESI | Buy | ELEMENT SOLUTIONS INC | $13,408,926 | +16.7% | 683,780 | +14.2% | 0.24% | +24.2% |
BRKR | Sell | BRUKER CORP | $13,105,740 | -19.7% | 210,365 | -4.7% | 0.24% | -14.5% |
INZY | New | INOZYME PHARMA INC | $13,125,000 | – | 3,125,000 | +100.0% | 0.24% | – |
Buy | GXO LOGISTICS INCORPORATED | $12,913,264 | -6.6% | 220,175 | +0.0% | 0.23% | -0.9% | |
EQT | New | EQT CORP | $12,831,396 | – | 316,200 | +100.0% | 0.23% | – |
DNLI | Buy | DENALI THERAPEUTICS INC | $12,828,766 | +38.7% | 621,850 | +98.4% | 0.23% | +48.1% |
RARE | ULTRAGENYX PHARMACEUTICAL IN | $12,798,350 | -22.7% | 359,000 | 0.0% | 0.23% | -17.9% | |
IEX | Sell | IDEX CORP | $12,125,902 | -7.9% | 58,292 | -4.7% | 0.22% | -1.8% |
NTLA | Sell | INTELLIA THERAPEUTICS INC | $11,783,667 | -41.4% | 372,665 | -24.4% | 0.21% | -37.6% |
EHC | Sell | ENCOMPASS HEALTH CORP | $11,424,453 | -11.2% | 170,108 | -10.5% | 0.20% | -5.5% |
EGP | Buy | EASTGROUP PPTYS INC | $11,066,585 | +91.7% | 66,454 | +99.8% | 0.20% | +103.1% |
R1 RCM INC | $11,087,074 | -18.3% | 735,705 | 0.0% | 0.20% | -13.1% | ||
ARDX | New | ARDELYX INC | $10,995,600 | – | 2,695,000 | +100.0% | 0.20% | – |
CERE | CEREVEL THERAPEUTICS HLDNG I | $10,696,700 | -31.3% | 490,000 | 0.0% | 0.19% | -27.0% | |
RVMD | Buy | REVOLUTION MEDICINES INC | $9,992,480 | +3.6% | 361,000 | +0.1% | 0.18% | +10.4% |
FREQ | New | FREQUENCY THERAPEUTICS INC | $9,999,999 | – | 3,597,122 | +100.0% | 0.18% | – |
MASS | 908 DEVICES INC | $9,530,427 | -2.9% | 1,430,995 | 0.0% | 0.17% | +3.0% | |
IDYA | New | IDEAYA BIOSCIENCES INC | $9,038,300 | – | 335,000 | +100.0% | 0.16% | – |
VRSK | Sell | VERISK ANALYTICS INC | $8,949,007 | -35.2% | 37,881 | -38.0% | 0.16% | -30.9% |
PLD | Sell | PROLOGIS INC. | $8,915,646 | -62.2% | 79,455 | -58.7% | 0.16% | -59.9% |
SYY | Sell | SYSCO CORP | $8,914,042 | -37.2% | 134,959 | -29.5% | 0.16% | -33.3% |
VKTX | VIKING THERAPEUTICS INC | $8,302,500 | -31.7% | 750,000 | 0.0% | 0.15% | -27.3% | |
INBX | New | INHIBRX INC | $7,964,377 | – | 434,026 | +100.0% | 0.14% | – |
EQIX | Buy | EQUINIX INC | $7,702,714 | +3.2% | 10,606 | +11.4% | 0.14% | +9.5% |
ANAB | New | ANAPTYSBIO INC | $7,668,920 | – | 427,000 | +100.0% | 0.14% | – |
ELS | Sell | EQUITY LIFESTYLE PPTYS INC | $6,973,378 | -57.7% | 109,455 | -55.6% | 0.12% | -55.2% |
BEAM | Sell | BEAM THERAPEUTICS INC | $6,285,708 | -57.1% | 261,360 | -43.1% | 0.11% | -54.4% |
PTGX | PROTAGONIST THERAPEUTICS INC | $5,337,600 | -39.6% | 320,000 | 0.0% | 0.10% | -35.6% | |
GPI | New | GROUP 1 AUTOMOTIVE INC | $4,630,142 | – | 17,231 | +100.0% | 0.08% | – |
RCUS | ARCUS BIOSCIENCES INC | $4,308,000 | -11.6% | 240,000 | 0.0% | 0.08% | -6.1% | |
VST | New | VISTRA CORP | $3,753,919 | – | 113,138 | +100.0% | 0.07% | – |
INTA | New | INTAPP INC | $2,882,150 | – | 85,983 | +100.0% | 0.05% | – |
New | TURNSTONE BIOLOGICS CORP | $2,790,769 | – | 708,317 | +100.0% | 0.05% | – | |
Buy | ARTERIS INC | $2,597,640 | -4.5% | 399,023 | +0.1% | 0.05% | +2.2% | |
MDB | New | MONGODB INCcl a | $2,521,665 | – | 7,291 | +100.0% | 0.04% | – |
PXD | New | PIONEER NAT RES CO | $1,592,618 | – | 6,938 | +100.0% | 0.03% | – |
XOMETRY INCnote 1.000% 2/0 | $1,530,948 | -3.6% | 2,100,000 | 0.0% | 0.03% | +3.7% | ||
NOW | Buy | SERVICENOW INC | $811,051 | +59.3% | 1,451 | +60.2% | 0.02% | +66.7% |
ALV | New | AUTOLIV INC | $815,256 | – | 8,450 | +100.0% | 0.02% | – |
SPGI | New | S&P GLOBAL INC | $831,308 | – | 2,275 | +100.0% | 0.02% | – |
SHOP | New | SHOPIFY INCcl a | $729,601 | – | 13,370 | +100.0% | 0.01% | – |
EW | Buy | EDWARDS LIFESCIENCES CORP | $678,528 | +40.8% | 9,794 | +91.7% | 0.01% | +50.0% |
New | LINDE PLC | $684,752 | – | 1,839 | +100.0% | 0.01% | – | |
ALGN | Buy | ALIGN TECHNOLOGY INC | $587,741 | +41.1% | 1,925 | +63.4% | 0.01% | +57.1% |
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $595,178 | +62.0% | 6,849 | +88.2% | 0.01% | +83.3% |
NVDA | Sell | NVIDIA CORPORATION | $498,499 | -4.1% | 1,146 | -6.8% | 0.01% | 0.0% |
WM | New | WASTE MGMT INC DEL | $483,692 | – | 3,173 | +100.0% | 0.01% | – |
ZTS | New | ZOETIS INCcl a | $389,019 | – | 2,236 | +100.0% | 0.01% | – |
COMP | Sell | COMPASS INCcl a | $323,678 | -28.2% | 111,613 | -13.4% | 0.01% | -25.0% |
NEE | Exit | NEXTERA ENERGY INC | $0 | – | -3,163 | -100.0% | -0.00% | – |
Exit | NERDWALLET INC | $0 | – | -150,000 | -100.0% | -0.02% | – | |
IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -110,000 | -100.0% | -0.08% | – |
NDAQ | Exit | NASDAQ INC | $0 | – | -182,708 | -100.0% | -0.15% | – |
ETNB | Exit | 89BIO INC | $0 | – | -642,073 | -100.0% | -0.21% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -562,233 | -100.0% | -0.30% | – |
Exit | HASHICORP INC | $0 | – | -749,122 | -100.0% | -0.33% | – | |
CWEN | Exit | CLEARWAY ENERGY INCcl c | $0 | – | -771,386 | -100.0% | -0.37% | – |
APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -397,141 | -100.0% | -0.61% | – |
KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -1,927,000 | -100.0% | -1.25% | – |
DOCS | Exit | DOXIMITY INCcl a | $0 | – | -3,893,633 | -100.0% | -2.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 43 | Q2 2024 | 3.2% |
PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
VERACYTE INC | 41 | Q2 2024 | 1.5% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-27 |
13F-HR | 2024-08-13 |
SC 13G/A | 2024-08-09 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.